| About the author: |
N. E. Lapovets, V. M. Akimova, L. E. Lapovets, N. R. Demianchuk, O. I. Martianova, M. M. Shchurko |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Despite the high level of development of modern diagnostics, there is still a problem of diagnosing extrapulmonary and latent forms of tuberculosis. The purpose of the study was to determine the features of the immune status during the Koch immunoprovocation test. Studies were conducted in the venous blood of 50 patients with abdominal tuberculosis before and 72 hours after the Koch skin test. Indicators of cellular immunity were determined by the indirect immunofluorescence method and the content of cytokines by the immunoenzymatic method. The existence of statistically significant differences in the immunogram and in the cytokine profile of the examined patients before and after the Koch test was proved. The Koch immunoprovocation test exacerbates the pathogenetic manifestations of the chronic inflammatory process, which is manifested by a change in the cytokine spectrum of the blood and makes it possible to clarify the diagnosis of abdominal tuberculosis. Determination of the level of TNF-α in the blood serum of patients after the Koch test can be a marker of the latent form of the course of abdominal tuberculosis. |
| Tags |
immune system,cytokines,extrapulmonary tuberculosis,Koch test |
| Bibliography |
- Abu-Zidan Fikri M, Mohamud Sheek-Hussein. Diagnosis of abdominal tuberculosis: lessons learned over 30 years: pectoral assay. World Journal of Emergency Surgery. 2019; 14(1): 1–7. doi: https://doi.org/10.1186/s13017-019-0252-3.
- Choudhury A, Dhillon J, Sekar A, Gupta P, Singh H, Sharma V. Differentiating gastrointestinal tuberculosis and Crohn's disease - a comprehensive review. BMC Gastroenterol. 2023; 23: 246. doi: https://doi.org/10.1186/s12876-023-02887-0.
- Dhali A, Das K, Dhali GK, Ghosh R, Sarkar A, Misra D. Abdominal tuberculosis: Clinical profile and outcome. The International Journal of Mycobacteriology. 2021; 10(4): 414–420. doi: 10.4103/ijmy.ijmy_195_21.
- Feruglio SL, Tonby K, Kvale D, Dyrhol‐Riise AM. Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection. Clinical & Experimental Immunology. 2015; 179(3): 454–465. doi:https: //doi.org/10.1111/cei.12468.
- Gao X, Guo X, Li M, et al. Interleukin 8 and pentaxin (C-reactive protein) as potential new biomarkers of bovine tuberculosis. Journal of Clinical Microbiology. 2019; 57(10): 1110–1128. doi:https: //doi.org/10.1128/jcm.00274-19.
- Gualanoa Gina, Mencarinia Paola, Lauria Francesco Nicola, et al. Tuberculin skin test–Outdated or still useful for Latent TB infection screening? International Journal of Infectious Diseases. 2019; 80: S20-S22. doi: https://doi.org/10.1016/j.ijid.2019.01.048.
- Goldstein Ellie JC, Lee Elsie, Holzman Robert S. Evolution and Current Use of the Tuberculin Test. Clinical Infectious Diseases. 2002; 34(3): 365–370. doi: https://doi.org/10.1086/ 338149.
- Goletti D, Sanduzzi A, Delogu G. Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. The Journal of Rheumatology Supplement. 2014; 91: 24–31. doi: 10.3899/jrheum.140099.
- Kestler B, Tyler SK. Latent tuberculosis testing through the ages: the search for a sleeping killer. Am J Physiol Lung Cell Mol Physiol. 2022; Mar 1;322(3): L412–L419. doi: 10.1152/ajplung.00217.2021.
- Pourakbari B, Mamishi S, Benvari S, Mahmoudi S. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-gamma release assays: a systematic review and meta-analysis. Adv. Med. Sci. 2019; 64: 437–443. doi: 10.1016/j.advms.2019.09.001.
- Silvério D, Gonçalves R, Appelberg R, Saraiva M. Advances on the Role and Applications of Interleukin-1 in Tuberculosis. MBio. 2021;12(6): e03134–21. doi:https:// doi.org/10.1128/mBio.03134-21.
- Waters WR, Maggioli MF, Palmer MV, Thacker TC, McGil JL, Vordermeier HM. Interleukin-17A as a biomarker for bovine tuberculosis. Vaccine Immunology. 2016; 23(2): 168–180. doi: https://doi.org/10.1128/CVI.00637-15.
- Yareshko AG, Kulish MV. Glucocorticoids as immunostimulators in pathogenetic therapy of tuberculosis. The world of medicine and biology. 2020; 3 (73): 144–148. doi:10.26724/2079-8334-2020-3-73-144-148.
- Zeng J, Zhou G, Pan F. Clinical Analysis of Intestinal Tuberculosis: A Retrospective Study. Journal of Clinical Medicine. 2023; 12(2): 445. https://doi.org/10.3390/jcm12020445.
|
| Publication of the article |
«World of Medicine and Biology» №1(87), 2024 year, 100-103 pages, index UDK 617.55-002.5-07:616.155-097.36-07 |
| DOI |
10.26724/2079-8334-2024-1-87-100-103 |
